Table 1.
Previous experience with psychedelic substances in full/regular psychedelic doses and low/micro doses of the whole sample (n = 233).
| Full or MD | Full dose experience | Microdose experience | |
|---|---|---|---|
| n (%) | 191 (82.0%) | 178 (76.4%) | 101 (43.3%) |
| Psilocybin/psilocin (e.g., magic mushrooms, truffles) | 165 (70.8%) | 152 (65.2%) | 77 (33.0%) |
| LSD | 111 (47.6%) | 102 (43.8%) | 43 (18.5%) |
| Ayahuasca | 40 (17.2%) | 38 (16.3%) | 4 (1.7%) |
| DMT | 38 (16.3%) | 37 (15.9%) | 5 (2.1%) |
| Salvia divinorum | 24 (10.3%) | 24 (10.3%) | 1 (0.4%) |
| Novel lysergamides (e.g., 1P-LSD, ALD-52) | 18 (7.7%) | 16 (6.9%) | 10 (4.3%) |
| Mescaline | 14 (6.0%) | 13 (5.6%) | 3 (1.3%) |
| 5-MeO-DMT | 8 (3.4%) | 7 (3.0%) | 1 (0.4%) |
| Ibogaine | 2 (0.9%) | 2 (0.9%) | 1 (0.4%) |